Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
A phase 3 trial of Epirubicin and Ethiodized oil in Hepatocellular carcinoma, run by Shanghai Zhongshan Hospital, with a status the registry has not verified recently.
Overview
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus is a phase 3 interventional study registered as NCT02971345 by Shanghai Zhongshan Hospital, with 253 participants planned, started 2017-01 and due to reach its primary completion in 2020-10. Interventions recorded: Stent and Iodine-125 seed strand implantation, Stent, Iodine-125 seed, Epirubicin, Ultra-fluid lipiodol, Gelatin sponge articles. Conditions recorded: Hepatocellular Carcinoma, Portal Vein Tumor Thrombus.
Linked to the drug Ethiodized oil because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialTransarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Shares Ethiodized oil, Hepatocellular carcinoma and the tag pipeline.
- TrialLiver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
Shares Ethiodized oil, Hepatocellular carcinoma and the tag pipeline.
- TrialEfficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialPrecise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids
Shares Epirubicin and the tag pipeline.
- TrialOri-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialA Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialThermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialSafety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
Shares Epirubicin and the tag pipeline.